Correlation Between PYC Therapeutics and FSA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PYC Therapeutics and FSA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PYC Therapeutics and FSA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PYC Therapeutics and FSA Group, you can compare the effects of market volatilities on PYC Therapeutics and FSA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PYC Therapeutics with a short position of FSA. Check out your portfolio center. Please also check ongoing floating volatility patterns of PYC Therapeutics and FSA.

Diversification Opportunities for PYC Therapeutics and FSA

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between PYC and FSA is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding PYC Therapeutics and FSA Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSA Group and PYC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PYC Therapeutics are associated (or correlated) with FSA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSA Group has no effect on the direction of PYC Therapeutics i.e., PYC Therapeutics and FSA go up and down completely randomly.

Pair Corralation between PYC Therapeutics and FSA

Assuming the 90 days trading horizon PYC Therapeutics is expected to under-perform the FSA. In addition to that, PYC Therapeutics is 4.72 times more volatile than FSA Group. It trades about -0.29 of its total potential returns per unit of risk. FSA Group is currently generating about 0.07 per unit of volatility. If you would invest  81.00  in FSA Group on September 27, 2024 and sell it today you would earn a total of  1.00  from holding FSA Group or generate 1.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

PYC Therapeutics  vs.  FSA Group

 Performance 
       Timeline  
PYC Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
FSA Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FSA Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, FSA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

PYC Therapeutics and FSA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PYC Therapeutics and FSA

The main advantage of trading using opposite PYC Therapeutics and FSA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PYC Therapeutics position performs unexpectedly, FSA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSA will offset losses from the drop in FSA's long position.
The idea behind PYC Therapeutics and FSA Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.